• 2025
  Puszko AK, Batista FA, Ejjoummany A, Bouillon A, Maurel M, Adler P, Legru A, Martinez M, Ortega Varga L, Hadjadj M, Alzari PM, Blondel A, Haouz A, Barale JC, Hernandez JF, Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints., ChemMedChem 2025 Jan; (): e202400924.
• 2024
  Legru A, Batista FA, Puszko AK, Bouillon A, Maurel M, Martinez M, Ejjoummany A, Ortega Varga L, Adler P, Méchaly A, Hadjadj M, Sosnowski P, Hopfgartner G, Alzari PM, Blondel A, Haouz A, Barale JC, Hernandez JF, Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1., Eur J Med Chem 2024 Apr; 269(): 116308.
• 2022
  Al-Dahmani ZM, Li X, Wiggenhauser LM, Ott H, Kruithof PD, Lunev S, A Batista F, Luo Y, Dolga AM, Morton NM, Groves MR, Kroll J, van Goor H, , Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes., Sci Rep 2022 07; 12(1): 12077.
• 2021
  Martins MB, de Assis Batista F, Marcello MA, Bufalo NE, Peres KC, Morari EC, Soares FA, Vassallo J, Ward LS, , Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions., Ann Diagn Pathol 2021 Aug; 53(): 151766.
• 2020
  Martins MB, de Assis Batista F, Bufalo NE, Peres KC, Meneghetti M, da Assumpção LVM, Ward LS, , Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population., Endocrine 2020 Sep; (): .
• 2020
  Kruithof PD, Lunev S, Aguilar Lozano SP, de Assis Batista F, Al-Dahmani ZM, Joles JA, Dolga AM, Groves MR, van Goor H, , Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases., Biochim Biophys Acta Mol Basis Dis 2020 06; 1866(6): 165716.
• 2020
  Bosch SS, Lunev S, Batista FA, Linzke M, Kronenberger T, Dömling ASS, Groves MR, Wrenger C, , Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2., ACS Infect Dis 2020 05; 6(5): 986-999.
• 2020
  Wibowo JP, Batista FA, van Oosterwijk N, Groves MR, Dekker FJ, Quax WJ, , A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa., Int J Biol Macromol 2020 Mar; 146(): 212-221.
• 2020
  Batista FA, Gyau B, Vilacha JF, Bosch SS, Lunev S, Wrenger C, Groves MR, , New directions in antimalarial target validation., Expert Opin Drug Discov 2020 02; 15(2): 189-202.
• 2019
  Batista FA, Bosch SS, Butzloff S, Lunev S, Meissner KA, Linzke M, Romero AR, Wang C, Müller IB, Dömling ASS, Groves MR, Wrenger C, , Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum., Microbiologyopen 2019 Feb; (): e779.
• 2018
  Lunev S, Bosch SS, Batista FA, Wang C, Li J, Linzke M, Kruithof P, Chamoun G, Dömling ASS, Wrenger C, Groves MR, , Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase., Biochem Biophys Res Commun 2018 03; 497(3): 835-842.
• 2018
  Martins MB, Marcello MA, Batista FA, Peres KC, Meneghetti M, Ward MAL, Etchebehere ECSC, da Assumpção LVM, Ward LS, , Serum interleukin measurement may help identify thyroid cancer patients with active disease., Clin Biochem 2018 Feb; 52(): 1-7.
• 2018
  Lunev S, Butzloff S, Romero AR, Linzke M, Batista FA, Meissner KA, Müller IB, Adawy A, Wrenger C, Groves MR, , Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro., PLoS One 2018 ; 13(4): e0195011.
• 2017
  Boonstra PA, Gietema JA, Suurmeijer AJH, Groves MR, de Assis Batista F, Schuuring E, Reyners AKL, , Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature., Oncotarget 2017 Dec; 8(65): 109836-109847.
• 2017
  Meissner KA, Lunev S, Wang YZ, Linzke M, de Assis Batista F, Wrenger C, Groves MR, , Drug Target Validation Methods in Malaria – Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation., Curr Drug Targets 2017 ; 18(9): 1069-1085.
• 2016
  Lunev S, Bosch SS, Batista Fde A, Wrenger C, Groves MR, , Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum., Acta Crystallogr F Struct Biol Commun 2016 07; 72(Pt 7): 523-33.
• 2016
  Batista FA, Ward LS, Marcello MA, Martins MB, Peres KC, Torricelli C, Bufalo NE, Soares FA, da Silva MJ, Assumpção LV, , Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression., J Endocrinol Invest 2016 Apr; 39(4): 423-9.
• 2014
  Marcello MA, Cunha LL, Batista FA, Ward LS, , Obesity and thyroid cancer., Endocr Relat Cancer 2014 Oct; 21(5): T255-71.
• 2014
  Martins MB, Marcello MA, Batista Fde A, Cunha LL, Morari EC, Soares FA, Vassallo J, Ward LS, , CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors., J Immunol Res 2014 ; 2014(): 921864.